The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors by Suying Lu, Suying Lu, Ye Hong, Ye Hong, Huimou Chen, Huimou Chen, Liuhong Wu, Liuhong Wu, Feifei Sun, Feifei Sun, Juan Wang, Juan Wang, Jia Zhu, Jia Zhu, Yi Que, Yi Que, Lian Zhang, Lian Zhang, Zijun Zhen, Zijun Zhen, Xiaofei Sun, Xiaofei Sun, Junting Huang, Junting Huang, Yizhuo Zhang, Yizhuo Zhang

Connect to this object online.